![David Altarac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Altarac
Direttore Tecnico/Scientifico/R&S presso
ENTASIS THERAPEUTICS HOLDINGS INC.
Profilo
David Altarac is currently the Chief Medical Officer at Entasis Therapeutics, Inc. and Entasis Therapeutics Holdings, Inc. He previously held positions as SVP & Head-Regulatory, Safety & Compliance at Shire Plc, Vice President-Regulatory Affairs at NeoStem, Inc., and Vice President-Regulatory Affairs at Caladrius Biosciences, Inc. Altarac has a graduate degree from New York University, a doctorate from New York Medical College, an undergraduate degree from State University of New York at Binghamton, and a graduate degree from NYU Wagner.
Posizioni attive di David Altarac
| Società | Posizione | Inizio |
|---|---|---|
| ENTASIS THERAPEUTICS HOLDINGS INC. | Direttore Tecnico/Scientifico/R&S | 04/11/2019 |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Direttore Tecnico/Scientifico/R&S | 04/11/2019 |
Precedenti posizioni note di David Altarac
| Società | Posizione | Fine |
|---|---|---|
NeoStem, Inc. /Old/
 NeoStem, Inc. /Old/ Other TransportationTransportation Operates a commercial autologous adult stem cell bank | Consigliere Generale | 01/06/2015 |
| SHIRE | Responsabile della Conformità | - |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Consigliere Generale | - |
Formazione di David Altarac
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
9
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeoStem, Inc. /Old/
NeoStem, Inc. /Old/ Other TransportationTransportation Operates a commercial autologous adult stem cell bank | Transportation |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NYU Wagner
 NYU Wagner Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
